The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030
Written by james hebrewSubcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling ..